Enteroendocrine cells express functional Toll-like receptors, AJP: Gastrointestinal and Liver Physiology, vol.292, issue.6, pp.1770-1783, 2007. ,
DOI : 10.1152/ajpgi.00249.2006
URL : http://ajpgi.physiology.org/content/ajpgi/292/6/G1770.full.pdf
Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein???Coupled Bile Acid Receptors, Endocrinology, vol.156, issue.11, pp.3961-3970, 2015. ,
DOI : 10.1210/en.2015-1321
URL : https://academic.oup.com/endo/article-pdf/156/11/3961/20218189/endo3961.pdf
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol.58, issue.8, pp.1091-1103, 2009. ,
DOI : 10.1136/gut.2008.165886
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice, Cell Metabolism, vol.25, issue.4, pp.927-934, 2017. ,
DOI : 10.1016/j.cmet.2017.02.008
Radiation-induced oxidative injury of the ileum and colon is alleviated by glucagon-like peptide-1 and -2, Journal of Radiation Research and Applied Sciences, vol.8, issue.2, pp.234-242, 2015. ,
DOI : 10.1016/j.jrras.2015.01.010
The Cardiovascular Biology of Glucagon-like Peptide-1, Cell Metabolism, vol.24, issue.1, pp.15-30, 2016. ,
DOI : 10.1016/j.cmet.2016.06.009
Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2, Annual Review of Physiology, vol.76, issue.1, pp.561-583, 2014. ,
DOI : 10.1146/annurev-physiol-021113-170317
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells, Nature Medicine, vol.46, issue.11, pp.1481-1489, 2011. ,
DOI : 10.1007/s00125-003-1080-1
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286294/pdf
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation, Am. J. Clin. Nutr, vol.86, pp.1286-1292, 2007. ,
Chronic Exposure to TNF?? Impairs Secretion of Glucagon-Like Peptide-1, Endocrinology, vol.156, issue.11, pp.3950-3960, 2015. ,
DOI : 10.1210/en.2015-1361
URL : https://academic.oup.com/endo/article-pdf/156/11/3950/8987007/endo3950.pdf
The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans, International Reviews of Immunology, vol.87, issue.2, pp.189-218, 2016. ,
DOI : 10.2337/dc09-0979
The Physiology of Glucagon-like Peptide 1, Physiological Reviews, vol.87, issue.4, pp.1409-1439, 2007. ,
DOI : 10.1152/physrev.00034.2006
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J. Immunol, vol.162, pp.3749-3752, 1999. ,
Glucose homeostasis, nutrition and infections during critical illness, Clinical Microbiology and Infection, 2017. ,
DOI : 10.1016/j.cmi.2016.12.033
Epithelial cells as sensors for microbial infection., Journal of Clinical Investigation, vol.100, issue.1, pp.6-10, 1997. ,
DOI : 10.1172/JCI119522
URL : http://www.jci.org/articles/view/119522/files/pdf
GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering, Diabetes, vol.63, issue.10, pp.3221-3229, 2014. ,
DOI : 10.2337/db14-0100
URL : http://diabetes.diabetesjournals.org/content/diabetes/63/10/3221.full.pdf
Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor, Peptides, vol.48, pp.36-44, 2013. ,
DOI : 10.1016/j.peptides.2013.07.022
I-FABP as Biomarker for the Early Diagnosis of Acute Mesenteric Ischemia and Resultant Lung Injury, PLoS ONE, vol.176, issue.12, 2014. ,
DOI : 10.1371/journal.pone.0115242.t001
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice, Regulatory Peptides, vol.179, issue.1-3, pp.91-100, 2012. ,
DOI : 10.1016/j.regpep.2012.08.016
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis, Gut, vol.29, issue.12, pp.1724-1733, 2013. ,
DOI : 10.1200/JCO.2010.32.4095
Changes in Colonic Mucosal Permeability in Mouse Colitis Induced with Dextran Sulfate Sodium., Experimental Animals, vol.48, issue.3, 1999. ,
DOI : 10.1538/expanim.48.137
GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7, Cell Metabolism, vol.21, issue.3, pp.379-391, 2015. ,
DOI : 10.1016/j.cmet.2015.02.005
URL : https://doi.org/10.1016/j.cmet.2015.02.005
GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease, The American Journal of Medicine, vol.130, issue.7, pp.833-841, 2017. ,
DOI : 10.1016/j.amjmed.2017.03.010
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control, Mediators of Inflammation, vol.38, issue.7, p.3094642, 2016. ,
DOI : 10.1007/s00395-015-0465-x
URL : http://doi.org/10.1155/2016/3094642
GLP-2 enhances barrier formation and attenuates TNF??-induced changes in a Caco-2 cell model of the intestinal barrier, Regulatory Peptides, vol.178, issue.1-3, pp.95-101, 2012. ,
DOI : 10.1016/j.regpep.2012.07.002
Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse, Journal of Experimental Medicine, vol.180, issue.1, pp.111-121, 1994. ,
DOI : 10.1084/jem.180.1.111
Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway, Diabetes, vol.63, issue.2, pp.471-482, 2014. ,
DOI : 10.2337/db13-0903
URL : https://hal.archives-ouvertes.fr/inserm-00880061
Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay, Journal of Lipid Research, vol.6, issue.7, pp.1363-1369, 2015. ,
DOI : 10.1210/jc.2013-3463
Fatty acid-binding proteins as plasma markers of tissue injury, Clinica Chimica Acta, vol.352, issue.1-2, pp.15-35, 2005. ,
DOI : 10.1016/j.cccn.2004.09.001
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene, Science, vol.282, issue.5396, pp.2085-2088, 1998. ,
DOI : 10.1126/science.282.5396.2085
Antagonism of central glucagon-like peptide-1 receptors enhances lipopolysaccharide-induced fever, Autonomic Neuroscience, vol.85, issue.1-3, pp.98-101, 2000. ,
DOI : 10.1016/S1566-0702(00)00227-7
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS, International Immunology, vol.20, issue.8, pp.961-970, 2008. ,
DOI : 10.1093/intimm/dxn055
Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats, AJP: Gastrointestinal and Liver Physiology, vol.293, issue.1, pp.288-295, 2007. ,
DOI : 10.1152/ajpgi.00453.2006
URL : http://ajpgi.physiology.org/content/ajpgi/293/1/G288.full.pdf
Effects of GLP-1 in the Kidney, Reviews in Endocrine and Metabolic Disorders, vol.33, issue.12, pp.197-207, 2014. ,
DOI : 10.1093/eurheartj/ehr309
Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis, Innate Immunity, vol.9, issue.2, pp.93-103, 2010. ,
DOI : 10.1177/09680519030090050901
Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice, Endocrinology, vol.154, issue.12, pp.4503-4511, 2013. ,
DOI : 10.1210/en.2013-1666
Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation, World Journal of Gastroenterology, vol.20, issue.40, pp.14821-14830, 2014. ,
DOI : 10.1016/j.physbeh.2010.02.029
The endogenous preproglucagon system is not essential for gut growth homeostasis in mice, Molecular Metabolism, vol.6, issue.7, pp.681-692, 2017. ,
DOI : 10.1016/j.molmet.2017.04.007
The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease: Figure 1, Biochemical Society Transactions, vol.43, issue.4, pp.727-733, 2015. ,
DOI : 10.1042/BST20150090
Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats, Microsurgery, vol.279, issue.4, pp.285-290, 2008. ,
DOI : 10.1093/infdis/161.5.982